Effects of orexins on the hypothalamic-pituitary-adrenal system

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

The effects of the recently identified neuropeptides orexin-A and orexin-B on the hypothalamic-pituitary-adrenal (HPA) system were investigated. An in vivo system was used to assess the central effects of both orexin-A and orexin-B. Different doses of the orexins (2.8-560 pmol) were administered intracerebroventricularly (i.c.v.) to adult male rats, and plasma corticosterone was used as an index of the degree of the activation of the HPA system. Both peptides exhibited a clear dose-response action, although orexin-B proved to be less effective than orexin-A. Pretreatment with the corticotropin-releasing hormone (CRH) antagonist α-helical CRH(9-41) completely prevented the action of the orexins. Orexin-A, orexin-B or adrenocorticotropic hormone (ACTH) was further administered intraperitoneally (i.p.). While ACTH evoked a significant adrenal response, the orexins did not influence the basal secretion. Adrenal slices, oxygenized and perifused with Krebs' solution, were also treated with orexin-A, orexin-B or ACTH. Both orexins failed to modify the release of corticosterone, but ACTH induced a marked adrenal response. This study suggests that these appetite-regulating peptides might activate the HPA system at a central level but neither orexin-A nor orexin-B appears to modulate directly the adrenal corticosterone release.

Original languageEnglish
Pages (from-to)1174-1178
Number of pages5
JournalJournal of Neuroendocrinology
Volume12
Issue number12
DOIs
Publication statusPublished - 2000

Fingerprint

Pituitary-Adrenal System
Adrenocorticotropic Hormone
Corticosterone
Orexins
Hormone Antagonists
Peptides

Keywords

  • Hypothalamic-pituitary-adrenal system
  • Orexin-A
  • Orexin-B
  • Stress response

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Effects of orexins on the hypothalamic-pituitary-adrenal system. / Jászberényi, M.; Bujdosó, E.; Pataki, I.; Telegdy, G.

In: Journal of Neuroendocrinology, Vol. 12, No. 12, 2000, p. 1174-1178.

Research output: Contribution to journalArticle

@article{8650cd7708924389ac8000a45a706dcd,
title = "Effects of orexins on the hypothalamic-pituitary-adrenal system",
abstract = "The effects of the recently identified neuropeptides orexin-A and orexin-B on the hypothalamic-pituitary-adrenal (HPA) system were investigated. An in vivo system was used to assess the central effects of both orexin-A and orexin-B. Different doses of the orexins (2.8-560 pmol) were administered intracerebroventricularly (i.c.v.) to adult male rats, and plasma corticosterone was used as an index of the degree of the activation of the HPA system. Both peptides exhibited a clear dose-response action, although orexin-B proved to be less effective than orexin-A. Pretreatment with the corticotropin-releasing hormone (CRH) antagonist α-helical CRH(9-41) completely prevented the action of the orexins. Orexin-A, orexin-B or adrenocorticotropic hormone (ACTH) was further administered intraperitoneally (i.p.). While ACTH evoked a significant adrenal response, the orexins did not influence the basal secretion. Adrenal slices, oxygenized and perifused with Krebs' solution, were also treated with orexin-A, orexin-B or ACTH. Both orexins failed to modify the release of corticosterone, but ACTH induced a marked adrenal response. This study suggests that these appetite-regulating peptides might activate the HPA system at a central level but neither orexin-A nor orexin-B appears to modulate directly the adrenal corticosterone release.",
keywords = "Hypothalamic-pituitary-adrenal system, Orexin-A, Orexin-B, Stress response",
author = "M. J{\'a}szber{\'e}nyi and E. Bujdos{\'o} and I. Pataki and G. Telegdy",
year = "2000",
doi = "10.1046/j.1365-2826.2000.00572.x",
language = "English",
volume = "12",
pages = "1174--1178",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Effects of orexins on the hypothalamic-pituitary-adrenal system

AU - Jászberényi, M.

AU - Bujdosó, E.

AU - Pataki, I.

AU - Telegdy, G.

PY - 2000

Y1 - 2000

N2 - The effects of the recently identified neuropeptides orexin-A and orexin-B on the hypothalamic-pituitary-adrenal (HPA) system were investigated. An in vivo system was used to assess the central effects of both orexin-A and orexin-B. Different doses of the orexins (2.8-560 pmol) were administered intracerebroventricularly (i.c.v.) to adult male rats, and plasma corticosterone was used as an index of the degree of the activation of the HPA system. Both peptides exhibited a clear dose-response action, although orexin-B proved to be less effective than orexin-A. Pretreatment with the corticotropin-releasing hormone (CRH) antagonist α-helical CRH(9-41) completely prevented the action of the orexins. Orexin-A, orexin-B or adrenocorticotropic hormone (ACTH) was further administered intraperitoneally (i.p.). While ACTH evoked a significant adrenal response, the orexins did not influence the basal secretion. Adrenal slices, oxygenized and perifused with Krebs' solution, were also treated with orexin-A, orexin-B or ACTH. Both orexins failed to modify the release of corticosterone, but ACTH induced a marked adrenal response. This study suggests that these appetite-regulating peptides might activate the HPA system at a central level but neither orexin-A nor orexin-B appears to modulate directly the adrenal corticosterone release.

AB - The effects of the recently identified neuropeptides orexin-A and orexin-B on the hypothalamic-pituitary-adrenal (HPA) system were investigated. An in vivo system was used to assess the central effects of both orexin-A and orexin-B. Different doses of the orexins (2.8-560 pmol) were administered intracerebroventricularly (i.c.v.) to adult male rats, and plasma corticosterone was used as an index of the degree of the activation of the HPA system. Both peptides exhibited a clear dose-response action, although orexin-B proved to be less effective than orexin-A. Pretreatment with the corticotropin-releasing hormone (CRH) antagonist α-helical CRH(9-41) completely prevented the action of the orexins. Orexin-A, orexin-B or adrenocorticotropic hormone (ACTH) was further administered intraperitoneally (i.p.). While ACTH evoked a significant adrenal response, the orexins did not influence the basal secretion. Adrenal slices, oxygenized and perifused with Krebs' solution, were also treated with orexin-A, orexin-B or ACTH. Both orexins failed to modify the release of corticosterone, but ACTH induced a marked adrenal response. This study suggests that these appetite-regulating peptides might activate the HPA system at a central level but neither orexin-A nor orexin-B appears to modulate directly the adrenal corticosterone release.

KW - Hypothalamic-pituitary-adrenal system

KW - Orexin-A

KW - Orexin-B

KW - Stress response

UR - http://www.scopus.com/inward/record.url?scp=0033677553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033677553&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2826.2000.00572.x

DO - 10.1046/j.1365-2826.2000.00572.x

M3 - Article

C2 - 11106974

AN - SCOPUS:0033677553

VL - 12

SP - 1174

EP - 1178

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 12

ER -